Related Experiment Video

Updated: Aug 11, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Predicting "unresectable" ovarian cancer: Taking aim at a moving target

Robert E Bristow

    Gynecologic Oncology
    |February 21, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
    10:58

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

    Published on: July 18, 2016

    Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
    07:54

    Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

    Published on: March 25, 2019

    Related Experiment Videos

    Last Updated: Aug 11, 2026

    Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
    08:55

    Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

    Published on: November 2, 2014

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
    10:58

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

    Published on: July 18, 2016

    Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
    07:54

    Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

    Published on: March 25, 2019

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Population-Level Trends in Lifestyle Factors and Early-Onset Breast, Colorectal, and Uterine Cancers.

    Cancers·2026

    Racial/ethnic disparities in time from diagnosis to surgical treatment for type I and type II endometrial carcinomas.

    Gynecologic oncology·2025

    Isolated low-grade serous carcinoma arising in inguinal lymph nodes in the setting of endosalpingiosis: A case report.

    Gynecologic oncology reports·2025

    Trends in the incidence and mutational landscape of advanced uterine cancer.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025

    Associated Trends in Obesity and Endometrioid Endometrial Cancer in the United States.

    Obstetrics and gynecology·2025

    Surgical Management of Gynecologic Cancers.

    Hematology/oncology clinics of North America·2024

    Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

    Gynecologic oncology·2026

    The role of metabolic and bariatric surgery for obesity management in endometrial intraepithelial neoplasia and endometrial cancer: A Society of Gynecologic Oncology and Society of American Gastrointestinal and Endoscopic Surgeons clinical practice statement.

    Gynecologic oncology·2026

    Dynamics of HER2 status in recurrent cervical cancer: Highlighting the clinical value of reassessment.

    Gynecologic oncology·2026

    Persistent low-level real human chorionic gonadotropin after gestational trophoblastic disease: Natural history and predictors of subsequent gestational trophoblastic neoplasia.

    Gynecologic oncology·2026

    A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor.

    Gynecologic oncology·2026

    Quality of life outcomes after sentinel lymph node biopsy in patients with early-stage cervical cancer: Results from the prospective multicentre SENTIX study.

    Gynecologic oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us